The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy
Open accessAbstract
PURPOSE: In the last decade numerous groups have shown that low levels of pretreatment serum total testosterone consistently predict more aggressive disease, worse prognosis and worse treatment response in patients with metastatic prostate cancer. Prior studies have not demonstrated this same correlation in patients with known localized disease. We rigorously tested pretreatment total testosterone levels as a potential staging and prognostic marker in a large cohort of 879 patients with localized cancer treated with radical prostatectomy. MATERIALS AND METHODS: We retrospectively reviewed the clinical records of 879 patients treated with radical prostatectomy between January 1, 1986 and June 30, 2002 from 9 hospital sites. Nonparametric tests were used to compare the relationship of pretreatment testosterone to other variables. Multivariate logistic regression analysis was used to assess clinical predictors of extraprostatic disease. Kaplan-Meier survival methods and Cox regression analysis were used to assess predictors of biochemical recurrence. RESULTS: Patients with non-organ confined prostate cancer (pT3-T4) showed significantly lower pretreatment total testosterone levels than those with organ confined cancer (pT1-T2) (nonparametric p = 0.041). In multivariate analysis pretreatment total testosterone emerged as a significant independent predictor of extraprostatic disease (p = 0.046). Total testosterone was not a significant predictor of biochemical (prostate specific antigen) recurrence (p = 0.467). CONCLUSIONS: Pretreatment total testosterone was an independent predictor of extraprostatic disease in patients with localized prostate cancer. As testosterone decreases patients have an increased likelihood of non-organ confined disease. Low testosterone was not predictive of biochemical recurrence, although trends observed dictate study in larger cohorts with mature followup.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Partin, A. W. (1997) · JAMA · doi:10.1001/jama.277.18.1445 · Cited by 1,794
HUGGINS, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,499
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?
HOFFMAN, M. A., DeWOLF, W. C., & MORGENTALER, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67812-3 · Cited by 322
Farkas, A., Schneider, D., Perrotti, M., Cummings, K. B., & Ward, W. S. (1998) · Urology · doi:10.1016/s0090-4295(98)00242-8 · Cited by 202
Follow-up Prostate Cancer Treatments After Radical Prostatectomy: a Population-Based Study
Lu-Yao, G. L., Potosky, A. L., Albertsen, P. C., Wasson, J. H., Barry, M. J., & Wennberg, J. E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.166 · Cited by 196
INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS
MILLER, L. R., PARTIN, A. W., CHAN, D. W., BRUZEK, D. J., DOBS, A. S., EPSTEIN, J. I., & WALSH, P. C. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62922-7 · Cited by 177
Prostatic Complications of Testosterone Replacement Therapy
Jackson, J. A., Waxman, J., & Spiekerman, A. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100157033 · Cited by 96
Association between prostate cancer and serum testosterone levels
Zhang, P. L., Rosen, S., Veeramachaneni, R., Kao, J., DeWolf, W. C., & Bubley, G. J. (2002) · The Prostate · doi:10.1002/pros.10140 · Cited by 79
Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma.
Iversen, P., Rasmussen, F., & Christensen, I. J. (1994) · PubMed · Cited by 51
Cited by
Discacciati, A., Orsini, N., & Wolk, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr603 · Cited by 278
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
Metadata
- Authors
- MASSENGILL, J. C., SUN, L., MOUL, J. W., WU, H., McLEOD, D. G., AMLING, C., LANCE, R., FOLEY, J., SEXTON, W., KUSUDA, L., CHUNG, A., SODERDAHL, D., & DONAHUE, T.
- Venue
- Journal of Urology
- Published
- 2003-05
- Volume
- 169
- Issue
- 5
- Pages
- 1670-1675
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2032800737
- Cited by
- 293
- References
- 12
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy. https://app.cochat.ai/papers/10.1097/01.ju.0000062674.43964.d0
- The paper
- MASSENGILL, J. C., SUN, L., MOUL, J. W., WU, H., McLEOD, D. G., AMLING, C., LANCE, R., FOLEY, J., SEXTON, W., KUSUDA, L., CHUNG, A., SODERDAHL, D., & DONAHUE, T. (2003). Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy. Journal of Urology. https://doi.org/10.1097/01.ju.0000062674.43964.d0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.